Abstract
Psoriatic arthritis (PsA) is a multisystemic inflammatory condition that can lead to disability and impaired quality of life. Anti-tumor necrosis factors (TNFs) are approved drugs for PsA with good control of symptoms and inhibition of disease progression. Latent tuberculosis infection reactivation is one of the important complications observed after treatment with TNF-α inhibitors. Here we present a case of PsA that was treated with 2 different types of anti-TNF drugs who was diagnosed with tuberculosis lymphadenitis even though receiving a 9-month preventive therapy. This case report emphasizes the importance of close follow-up and careful examination of the patients with rheumatological diseases using anti-TNF treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
